Navigation Links
Funding Patterns in the Global Pharma and Biotech Industry

NEW YORK, April 21, 2015 /PRNewswire/ -- This research service analyzes the various PEVC and merger and acquisition deals in the pharmaceuticals and biotechnology industry. The deals are analyzed based on their number and average value. Trends are also observed based on the geographic region and buyer types. The study delves into the nature of cross-border deals and takes into account various deal multiples such as enterprise value, percent sought, and stock premium rise of the target company.

Executive Summary

Key Trends in the Pharma and Biotech Industry

- Pharma and biotech industry stock market indices have outperformed those of other industries in the study period.

- Profitability is reducing in large pharmaceuticals companies.

- Patent expiry and revenue loss in pharma and biotech companies.

- Government efforts to contain drug prices.

- Increasing market demand for drugs.

- Declining research & development (R&D) by large pharma companies.

Key Findings

- The pharma and biotech industry witnessed a decline in the volume of both private equity (PE) and venture capital (VC) deals. This is in tune with the overall decline in deals in healthcare in the study period.

- The PE deal volume in the pharmaceuticals sector declined steadily during 2010–2014, while the biotechnology sector witnessed an increase in deal volume during 2010–2013 and a slight decline in 2014.

- The initial public offering (IPO) market for the pharma and biotech industry has experienced steady growth post-2012.

- Depleting pipeline and increased cost pressures have made mergers and acquisitions (M&As) a lifeline for strategic growth for leading participants of the pharmaceuticals sector.

Read the full report:

About Reportlinker

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Contact Clare:
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. Centrillion Receives NIH Funding for Genomic Technology Development
2. ACGT Surpasses $25 Million Funding Milestone with Two New Grants
3. Global Specimen Solutions, Inc. Closes Series A Funding
4. New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases
5. Glencoe Software Closes Seed Funding of Over $800,000
6. CMU, Highmark Health and Allegheny Health Network Announce Second Round of Funding for Disruptive Health Technology Institute Projects
7. Draper Wins GSK Funding for Smaller, Smarter Implantable Devices
8. PureTech Announces Expansion with Oversubscribed $55M Funding Round
9. New Medical Device For Dogs Fights Oral Bacteria While He Plays; Crowdfunding Launches Today
10. National Anti-Vivisection Society Responds to NIH Decision to End Funding for Research Using "Class B" Dogs
11. Synedgen Awarded National Cancer Institute Funding for Promising New Treatment for Medical Radiation-induced Bowel Injury
Post Your Comments:
(Date:11/12/2019)... ... November 12, 2019 , ... ... welcomed their new Director of Forensic Genealogy, Melinde Lutz Byrne, to the organization. ... to ultimately provide investigative leads to law enforcement through proven genealogy and ...
(Date:11/6/2019)... ... 2019 , ... LeadingBiotech ,?an exclusive event series bringing ... East/West CEO conference to be held January 11-12, 2020 at the ... week of the J.P. Morgan Healthcare Conference and other biotech industry conferences, collectively ...
(Date:11/2/2019)... ... October 31, 2019 , ... ... used to communicating with each other: study managers, principal investigators, supply chain managers, ... a party is not informed of the latest data, potentially leading to patient ...
(Date:10/30/2019)... ... October 30, 2019 , ... Western University of Health ... and technology play in educating the next generation of health care providers. , ... presentations by WesternU administrators and representatives of companies working with the University on ...
Breaking Biology Technology:
(Date:11/6/2019)... ... November 06, 2019 , ... NDA Partners Chairman Carl ... executive with expertise in clinical pharmacology and pharmacometrics and a widely recognized expert ... has joined the firm as an Expert Consultant. , Dr. Stanski has served ...
(Date:11/5/2019)... ... 05, 2019 , ... Catalent, the leading global provider of ... consumer health products, today announced it will present at the upcoming World Orphan ... – 14, 2019. , On Wednesday, Nov. 13 at 3:20 p.m., Philip Wills, ...
(Date:11/2/2019)... ... November 01, 2019 , ... Stay on top of current hot topics ... Access to all webinars is free, so be sure to register today to save ... to see our upcoming webinars: , CLINICAL OPERATIONS , November 14 ...
Breaking Biology News(10 mins):